Crisis Intervention Services
33 places
Worldwide report
Every place
- 66Reports naming them
- 2Markets they lead in
- 33Regions & countries
- 5Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by Acadia Healthcare or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Where they show up
66 reportsOur reports that name Acadia Healthcare as a key player, by category and place.
- Healthcare Services · 66
Places 33
- Africa 2
- APAC 2
- Australia 2
- Brazil 2
- Canada 2
- China 2
- Ecuador 2
- Egypt 2
- Europe 2
France 2- Germany 2
- Global 2
Hong Kong 2
India 2
Italy 2
Japan 2
Kenya 2- Latin America 2
Malaysia 2
Mexico 2- Middle East 2
New Zealand 2- North America 2
Philippines 2
Russia 2
Saudi Arabia 2
Singapore 2
South Africa 2
Spain 2
Thailand 2- UAE 2
UK 2
US 2
Acadia Healthcare's markets
2Markets where they are a key player. Each opens the market's statistics for every place we cover.
Healthcare Services2
None of their markets match.
Recent reports naming Acadia Healthcare
Our newest markets with them as a key player. Each covers 2024 history, a 2025 base year and forecasts to 2034.
33 places
Substance Use Disorder Treatment
33 places
Worldwide report
Every place
Companies they compete with most
Named as key players in the same markets as Acadia Healthcare (number of shared markets).
Alkermes1 shared market
BICYCLE Health1 shared market
Crisis Text Line1 shared market
Indivior1 shared market
Orexo1 shared market
RI International1 shared market
Universal Health Services1 shared market
Vibrant Emotional Health1 shared market
Free public data on Acadia Healthcare
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
Company facts
- Website
- acadiahealthcare.com
- Home country
- United States
- Stock listing
- NASDAQ: ACHC
- Legal name
- ACADIA HEALTHCARE COMPANY, INC.
- Type
- Health services and software
Clinical trials
5 active studies led by Acadia Healthcare, of 41 in all
Source: ClinicalTrials.gov, Studies with Acadia Healthcare (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
US drug approvals
4 approvals with a product on the US market
- Daybue Stix NDA219884 · approved 11 Dec 2025
- Daybue NDA217026 · approved 10 Mar 2023
- Nuplazid NDA210793 · approved 28 Jun 2018
- Nuplazid NDA207318 · approved 29 Apr 2016
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.
SEC filings
Annual reports and other filings with the US Securities and Exchange Commission.
Source: SEC EDGAR, Company filings, CIK 1520697.
Trials over time
Studies Acadia Healthcare leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with Acadia Healthcare or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Also active in
Markets we cover where free public records show Acadia Healthcare: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets Acadia Healthcare is in.
From our blog
Stories on the topics Acadia Healthcare works in.
Bone and Joint Health: Supplements for an Ageing Population
1.71 billion people live with musculoskeletal conditions, including 528 million with osteoarthritis. Evidence…
Read
Eye Health Supplements: Screens, Ageing and Vision
2.2 billion people have a vision impairment. One supplement formula has strong trial evidence, but only for a…
Read
Adaptogens: Ancient Herbs, Modern Market
170 WHO Member States report the use of traditional medicine. Adaptogens like ashwagandha, rhodiola and…
Read